CANC expense ratio history
Tema Oncology ETF
Expense ratio: 0.99%
- In basis points
- 99 basis points
- Yearly cost per $10,000
- $99
- Prospectus dated
- 29 June 2026, filed with the SEC; rounded to 0.01%
Fee over time
Every figure we've recorded
| Date | Fee | What happened |
|---|---|---|
| 29 Jun 2026 | 0.99% | In the prospectusTotal annual fund operating expenses in the prospectus dated 2026-06-29 (form 485BPOS), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 485BPOS |
| 27 Jun 2025 | 0.99% | In the prospectusTotal annual fund operating expenses in the prospectus dated 2025-06-27 (form 497), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 497 |
| 28 Jun 2024 | 0.99% | In the prospectusTotal annual fund operating expenses in the prospectus dated 2024-06-28 (form 497), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 497 |
| 5 May 2023 | 0.99% | In the prospectusTotal annual fund operating expenses in the prospectus dated 2023-05-05 (form 497), from SEC bulk data, which rounds to 0.01%Source: SEC EDGAR filing, form 497 |
What this fee costs
Change the amount, years or return. The estimate keeps the fee at 0.99% and the return steady each year, the same assumptions as the cost example in a fund's prospectus.
$1,217 in fees over 10 years
After fees, $10,000 grows to $14,781.
| After | Fees paid |
|---|---|
| 1 year | $101 |
| 3 years | $317 |
| 5 years | $549 |
| 10 years | $1,217 |
How we read this figure
The figure is the total annual fund operating expenses line of the fee table in the fund's prospectus, as tagged in the fund company's filing with the SEC. The SEC publishes these figures rounded to four decimal places, so 0.015% appears as 0.02%. The fund company's own page may show a more precise number.
SEC filings give 4 prospectuses for this share class since 2023. Each one is listed above with a link to the filing.
More Tema ETF funds
The cheapest of 13. All Tema ETF funds.